Key result
Catheter ablation successfully treats hemodynamically significant VT in a patient supported by a BiVAD.
Why the study?
Electrophysiologic ablations in patients with ventricular assist devices have been limited to left VADs, with no prior reports in biventricular assist device patients.
Case Report (n=1)
This case demonstrates the feasibility of performing catheter ablation for ventricular tachycardia in patients supported by biventricular assist devices.
First VT ablation in BiVAD reported; hypothesis-generating and requires prospective validation before clinical adoption.
Ventricular assist devices (VADs) are playing a large role in the management of end-stage heart failure. Approximately 35% of patients with a VAD have ventricular arrhythmias within the first month of implantation.1 Electrophysiologic ablations in the setting of a VAD are limited to left VADs (LVADs). To our knowledge, we describe the first report of ablation of a hemodynamically significant ventricular tachycardia in a patient with a biventricular assist device (BiVAD).
No takes yet. Share an insight, caveat, or question.
Mulukutla et al. (2015) conducted a case report in Hemodynamically significant ventricular tachycardia with biventricular assist device support (n=1). Catheter ablation was evaluated on Successful ablation of ventricular tachycardia. Catheter ablation was successfully performed for hemodynamically significant ventricular tachycardia in a patient supported by a biventricular assist device.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: